Abstract:Kidney fibrosis, characterized by excessive extracellular matrix deposition, is a progressive disease that, despite affecting 10% of the population, lacks specific treatments and suitable biomarkers. This study presents a comprehensive, time-resolved multi-omics analysis of kidney fibrosis using an in vitro model system based on human kidney PDGFRβ+ mesenchymal cells aimed at unraveling disease mechanisms. Using transcriptomics, proteomics, phosphoproteomics, and secretomics we quantified over 14,000 biomolecules across seven time points following TGF-β stimulation. This revealed distinct temporal patterns in the expression and activity of known and potential kidney fibrosis markers and modulators. Data integration resulted in time-resolved multi-omic network models which allowed us to propose mechanisms related to fibrosis progression through early transcriptional reprogramming. Using siRNA knockdowns and phenotypic assays, we validated predictions and regulatory mechanisms underlying kidney fibrosis. In particular, we show that several early-activated transcription factors, including FLI1 and E2F1, act as negative regulators of collagen deposition and propose underlying molecular mechanisms. This work advances our understanding of the pathogenesis of kidney fibrosis and provides a resource to be further leveraged by the community.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the pathological mechanism of kidney fibrosis, as well as its potential treatment targets and biomarkers. Specifically, the research aims to reveal new mechanisms in the progression of kidney fibrosis through dynamic multi - omics analysis and mechanism modeling. The following are the specific objectives of this study: 1. **Reveal the molecular mechanism of kidney fibrosis**: By integrating transcriptomics, proteomics, phosphoproteomics and secretomics data, researchers hope to comprehensively understand the molecular changes at different time points during the process of kidney fibrosis, especially the impact of early - stage transcriptional reprogramming on disease progression. 2. **Discover new biomarkers and treatment targets**: Through the quantitative analysis of a large number of biomolecules, researchers expect to identify new biomarkers related to kidney fibrosis and potential treatment targets, so as to fill the gaps in current clinical management. 3. **Verify the key regulatory mechanisms**: Using siRNA knockdown and phenotypic experiments, verify the negative regulatory role of predicted key transcription factors (such as FLI1 and E2F1) in collagen deposition, and further clarify their molecular mechanisms. 4. **Construct a time - resolved multi - omics network model**: By integrating multi - omics data at different time points into the network model, researchers hope to propose time - dependent mechanisms related to fibrosis progression, thereby providing a theoretical basis for subsequent research. ### Research background Kidney fibrosis is a characteristic lesion of chronic kidney disease (CKD), manifested as excessive deposition and remodeling of the extracellular matrix (ECM), and ultimately leads to tissue structure destruction and organ failure. Although kidney fibrosis affects approximately 10% of the global population, there is currently a lack of specific treatment methods and suitable biomarkers. This has prompted researchers to deeply explore its molecular mechanisms in order to find new treatment strategies. ### Research methods The study used human PDGFRβ+ renal mesenchymal cells as an in vitro model system, induced the fibrosis process by TGF - β stimulation, and performed multi - omics analysis at multiple time points. These analyses include: - **Transcriptomics**: Tracking cell differentiation - **Proteomics and phosphoproteomics**: In - depth understanding of signal pathways - **Secretomics**: Measuring relevant ECM and signal components Through these methods, researchers obtained dynamic change data of more than 14,000 biomolecules and combined phenotypic readings for mechanism modeling. ### Main findings 1. **The role of early - stage transcription factors**: The study found that some early - activated transcription factors (such as FLI1 and E2F1) act as negative regulators of collagen deposition and proposed their potential molecular mechanisms. 2. **Complex time - dependent dynamic changes**: Through the integration of multi - omics data, the study revealed complex molecular change patterns in the fibrosis process, including changes in signal pathways, transcription factor activities and protein - protein interactions. 3. **Construct a multi - omics network model**: A network model of early - and late - stage fibrosis responses was constructed by the COSMOS method, demonstrating the importance of TGF - β signal transduction and ECM remodeling processes. In summary, this study not only deepens the understanding of the pathological mechanism of kidney fibrosis, but also provides valuable resources and directions for future treatments.

Dynamic multi-omics and mechanistic modeling approach uncovers novel mechanisms of kidney fibrosis progression

Single-cell transcriptomic profiling of kidney fibrosis identifies a novel specific fibroblast marker and putative disease target

Decoding myofibroblast origins in human kidney fibrosis

Single-cell sequencing dissects the transcriptional identity of activated fibroblasts and identifies novel persistent distal tubular injury patterns in kidney fibrosis

New tools to study renal fibrogenesis

Kidney Fibrosis: from Mechanisms to Therapeutic Medicines

Dysregulated Mesenchymal PDGFR‐β Drives Kidney Fibrosis

Single-cell analysis highlights differences in druggable pathways underlying adaptive or fibrotic kidney regeneration

Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression

Murine Precision-Cut Kidney Slices as an ex vivo Model to Evaluate the Role of Transforming Growth Factor-β1 Signaling in the Onset of Renal Fibrosis

Bile acid receptor agonist reverses TGF-β1-mediated fibrogenesis in human induced pluripotent stem cells (iPSC)-derived kidney organoids

Molecular Profiling Reveals a Common Metabolic Signature of Tissue Fibrosis

Emerging Roles Of Long Non-Coding Rnas In Renal Fibrosis

Epidermal growth factor receptor activation is essential for kidney fibrosis development

EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis

WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease

A Biomimetic Renal Fibrosis Progression Model On-Chip Evaluates Anti-Fibrotic Effects Longitudinally in a Dynamic Fibrogenic Niche.

Spatially resolved human kidney multi-omics single cell atlas highlights the key role of the fibrotic microenvironment in kidney disease progression

Identification and Functional Mechanism Verification of Novel MicroRNAs Associated with the Fibrosis Progression in Chronic Kidney Disease

Defining Therapeutic Targets for Renal Fibrosis: Exploiting the Biology of Pathogenesis

Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease